Cart (0 Items)
Your cart is currently empty.
View ProductsNormal Mouse IgG Isotype Control Antibody, FITC
| Size | 100T |
|---|---|
| Brand | Arovia |
| Product type | Primary Antibodies |
| Host Species | Mouse |
| Clonality | Polyclonal Antibody |
| Applications | FC |
| Isotype | IgG |
| Product name | Normal Mouse IgG Isotype Control Antibody, FITC |
|---|---|
| Buffer | 0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300. |
| Delivery condition | Blue ice (+4°C) |
| Delivery lead time in business days | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt. |
| Brand | Arovia |
| Host species | Mouse |
| Aliases /Synonyms | Anti-0 |
| Reference | FMB96411 |
| Note | For research use only. |
| Isotype | IgG |
| Clonality | Polyclonal Antibody |
Related products
Primary Antibodies
Anti-Human PAC-1 Antibody (PAC-1), FITC
FHC33331 409$
Primary Antibodies
Anti-Human CD349/FZD9 Antibody (2933#), FITC
FHA02811 465$
Primary Antibodies
Anti-Human CCL24/Eotaxin-2/MPIF-2 Antibody (SAA0461), FITC
FHA04011 411$
Primary Antibodies
Anti-Human CD284/TLR4 Antibody (SAA0095), FITC
FHA05311 465$
Primary Antibodies
Anti-Human CD261/TNFRSF10A/DR4 Antibody (SAA0083), FITC
FHA05911 465$
Primary Antibodies
Anti-Human CD277/BTN3A1 Antibody (103.2#), FITC
FHA13511 465$
Primary Antibodies
Anti-Human CLDN5/Claudin-5 Antibody (M23), FITC
FHA14111 465$
Primary Antibodies
Anti-Human CLDN5/Claudin-5 Antibody (M11), FITC
FHA14121 465$
Isotype Control
Normal Llama IgG Isotype Control Antibody, PerCP
FWC09314 270$
Secondary Antibody
Anti-Mouse APCDD1 Polyclonal Antibody
PMK99501 350$
Secondary Antibody
Anti-Mouse VSTM4 Polyclonal Antibody
PMK99301 350$
Secondary Antibody
Anti-Mouse Ccl6 Polyclonal Antibody
PMK98001 350$
Secondary Antibody
Anti-Mouse EGFLAM Polyclonal Antibody
PMK97901 350$Contact us
Send us a message from the form below
Reviews
There are no reviews yet.